Xact Kapitalforvaltning’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $1.95M | Hold |
17,900
| – | – | 0.04% | 346 |
|
|
2019
Q4 | $2.06M | Hold |
17,900
| – | – | 0.04% | 404 |
|
|
2019
Q3 | $1.44M | Buy |
17,900
+2,500
| +16% | +$201K | 0.03% | 463 |
|
|
2019
Q2 | $1.12M | Sell |
15,400
-7,700
| -33% | -$559K | 0.02% | 541 |
|
|
2019
Q1 | $2.16M | Buy |
23,100
+6,347
| +38% | +$593K | 0.05% | 351 |
|
|
2018
Q4 | $1.22M | Buy |
16,753
+1,608
| +11% | +$117K | 0.03% | 478 |
|
|
2018
Q3 | $1.33M | Sell |
15,145
-784
| -5% | -$68.6K | 0.03% | 513 |
|
|
2018
Q2 | $1.57M | Buy |
15,929
+486
| +3% | +$47.9K | 0.03% | 477 |
|
|
2018
Q1 | $1.84M | Buy |
15,443
+1,122
| +8% | +$134K | 0.04% | 418 |
|
|
2017
Q4 | $1.82M | Buy |
+14,321
| New | +$1.82M | 0.04% | 414 |
|
|
2016
Q4 | – | Sell |
-6,885
| Closed | -$467K | – | 640 |
|
|
2016
Q3 | $467K | Buy |
+6,885
| New | +$467K | 0.02% | 586 |
|